Login / Signup

The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers.

Robert P HebbelJacques ElionAbdullah Kutlar
Published in: American journal of hematology (2018)
Keyphrases
  • small molecule
  • cancer therapy
  • stem cells
  • drug delivery
  • mesenchymal stem cells
  • replacement therapy